KIF1A and EDNRB are differentially methylated in primary HNSCC and salivary rinses

Silencing of tumor suppressor genes plays a vital role in head and neck carcinogenesis. In this study, we aimed to evaluate to the utility of aberrant promoter hypermethylation for detection in a panel of 10 genes (KIF1A, EDNRB, CDH4, TERT, CD44, NISCH, PAK3, VGF, MAL and FKBP4) in head and neck squ...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of cancer Vol. 127; no. 10; pp. 2351 - 2359
Main Authors Demokan, Semra, Chang, Xiaofei, Chuang, Alice, Mydlarz, Wojciech K., Kaur, Jatinder, Huang, Peng, Khan, Zubair, Khan, Tanbir, Ostrow, Kimberly L., Brait, Mariana, Hoque, Mohammad O., Liegeois, Nanette J., Sidransky, David, Koch, Wayne, Califano, Joseph A.
Format Journal Article
LanguageEnglish
Published Hoboken Wiley Subscription Services, Inc., A Wiley Company 15.11.2010
Wiley-Blackwell
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Silencing of tumor suppressor genes plays a vital role in head and neck carcinogenesis. In this study, we aimed to evaluate to the utility of aberrant promoter hypermethylation for detection in a panel of 10 genes (KIF1A, EDNRB, CDH4, TERT, CD44, NISCH, PAK3, VGF, MAL and FKBP4) in head and neck squamous cell carcinoma (HNSCC) via a candidate gene approach. We investigated methylation of the gene promoters by bisulfite modification and quantitative methylation‐specific PCR (Q‐MSP) in a preliminary study of a limited cohort of salivary rinses from healthy subjects (n = 61) and patients with HNSCC (n = 33). The methylation status of 2 selected genes (EDNRB and KIF1A) were then analyzed in 15 normal mucosa samples from a healthy population, 101 HNSCC tumors and the corresponding salivary rinses from 71 out of the 101 HNSCC patients were collected before treatment. The promoter regions of CDH4, TERT, VGF, MAL, FKBP4, NISCH and PAK3 were methylated in normal salivary rinses while no methylation of CD44 was observed in either normal salivary rinses or tumor samples. However, KIF1A and EDNRB were methylated in 98 and 97% of primary HNSCC tissues respectively and were only methylated in 2 and 6.6% of normal salivary rinses. In addition, KIF1A and EDNRB were methylated in 38 and 67.6% of salivary rinses from HNSCC patients, respectively. Promoter hypermethylation of KIF1A and EDNRB is a frequent event in primary HNSCC, and these genes are preferentially methylated in salivary rinses from HNSCC patients. KIF1A and EDNRB are potential biomarkers for HNSCC detection.
Bibliography:Tel.: 410‐502‐5133, Fax: 1‐410‐614‐1411
Potential Conflicts of Interest
Under a licensing agreement between Oncomethylome Sciences, SA and The Johns Hopkins University, Dr. D. Sidransky is entitled to a share of royalty received by the University upon sales of diagnostic products described in this article. Dr. D. Sidransky owns Oncomethylome Sciences, SA stock, which is subject to certain restrictions under University policy. Dr. Sidransky is a paid consultant to Oncomethylome Sciences, SA and is a paid member of the company's Scientific Advisory Board. The Johns Hopkins University in accordance with its conflict of interest policies is managing the terms of this agreement. Dr. N. Liegeois is the President and Founder of Meridian Skin Care Ltd.
ISSN:0020-7136
1097-0215
DOI:10.1002/ijc.25248